ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

Tissue Bank Visibility Could Be Improved By Centralized Listing Of Resources: Panel

September 30, 1994

DRCCA Organization Still Not Complete; Division Will Chemoprevention

October 3, 1980

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000